Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Thiede

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Bone Marrow Transplantation|January 13, 2004
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysisJ Schetelig, M Bornhäuser, M Kiehl, et al.
Leukemia|November 20, 2015
Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemiaJ Balss, C Thiede, T Bochtler, et al.
Leukemia|December 8, 2010
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialF Stölzel, M Pfirrmann, W E Aulitzky, et al.
Leukemia|September 3, 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialU Platzbecker, M Wermke, J Radke, et al.
Annals of Hematology|May 6, 2004
Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cellsM Bornhäuser, T Illmer, P Le Coutre, et al.
Leukemia|March 10, 2001
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markersC Thiede, M Bornhäuser, U Oelschlägel, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Leukemia|July 11, 2017
Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AMLS Herold, K Sockel, C Sayehli, et al.
Leukemia|June 8, 2011
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groupsF Damm, F Thol, I Hollink, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|January 13, 2004
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysisJ Schetelig, M Bornhäuser, M Kiehl, et al.
Leukemia|November 20, 2015
Pretreatment d-2-hydroxyglutarate serum levels negatively impact on outcome in IDH1-mutated acute myeloid leukemiaJ Balss, C Thiede, T Bochtler, et al.
Leukemia|December 8, 2010
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trialF Stölzel, M Pfirrmann, W E Aulitzky, et al.
Leukemia|September 3, 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialU Platzbecker, M Wermke, J Radke, et al.
Annals of Hematology|May 6, 2004
Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cellsM Bornhäuser, T Illmer, P Le Coutre, et al.
Leukemia|March 10, 2001
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markersC Thiede, M Bornhäuser, U Oelschlägel, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Leukemia|July 11, 2017
Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AMLS Herold, K Sockel, C Sayehli, et al.
Leukemia|June 8, 2011
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groupsF Damm, F Thol, I Hollink, et al.
Pageof 15